Pregnancy has no impact on breast cancer, but can delay diagnosis and treatment

NewsGuard 100/100 Score

A new study finds women who develop breast cancer while pregnant or soon afterwards do not experience any differences in disease severity or likelihood of survival compared to other women with breast cancer.

The study is published in the March 15, 2009 issue of CANCER , a peer-reviewed journal of the American Cancer Society.

So-called pregnancy-associated breast cancers (PABC), defined as breast cancer that develops either during or within one year following pregnancy, is relatively rare and presents a dilemma for clinicians. An estimated 0.2 to 3.8 percent of pregnancies are complicated by breast cancer, and approximately 10 percent of breast cancer patients under age 40 develop the disease during pregnancy. But as age at the time of pregnancy continues to increase, the incidence of PABC can be expected to increase.

Previous research has suggested that pregnancy is associated with poorer outcomes among women with breast cancer. To clarify the issue, Drs. George Perkins, Beth Beadle and colleagues at The University of Texas M.D. Anderson Cancer Center analyzed data from 668 breast cancers in 652 patients aged 35 years or younger. Among that group, 104 breast cancers (15.6 percent) were pregnancy-associated: 51 cancers developed during pregnancy and 53 developed within one year following pregnancy.

There were no statistically significant differences in 10-year rates of cancer recurrence, cancer spread, or survival among patients with PABC compared with other women who developed breast cancer. However, pregnancy contributed to a delay in breast cancer diagnosis, evaluation and treatment. The researchers also found treatment during pregnancy improved survival compared with delaying treatment until after delivery among those who with PABC.

"Primary care and reproductive physicians should be aggressive in the work-up of breast symptoms in the pregnant population to expedite diagnosis and allow multidisciplinary treatment," the authors write. "Balancing the health of mother and child is… paramount; new evidence suggests that both can be prioritized and successful outcomes managed for both," they added.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New trials show promise for immune checkpoint blockers in early-stage lung cancer